Sri Lanka, Oct. 21 -- Premium International Injectable (Private) Limited is advancing the development of its pharmaceutical manufacturing facility in Sri Lanka, marking a significant step in the company's commitment to strengthening local manufacturing capabilities and establishing a foundation for future growth in the country's pharmaceutical sector.Book Beach Resorts

The state-of-the-art facility, which is being developed to European standards within a Board of Investment (BOI) zone, is intended to support the manufacture of biotechnology-based insulin and generic Small Volume Parenteral (SVP) products.

The plant is also geared to receive EU GMP certification, which is issued by National Competent Authorities (NCAs) within European Un...